Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone crossover study of glycocalyx function in kidney transplant recipients
ACTRN12616000966493Phase 2Terminated
- Sponsor
- Eastern Health Integrated Renal Service
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of spironolactone (2 arms), sponsored by Eastern Health Integrated Renal Service. Primary endpoint: Change in glycocalyx parameters. Started Aug 2016; status: terminated.
02
Drugs
spironolactone
Beyond the preview
Go deeper on ACTRN12616000966493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000966493.